Treatment of kidney cancer during the coronavirus pandemic

COVID-19 continues to affect the care of patients with metastatic renal cell carcinoma (RCC) and other cancers in a number of ways. Oncologists are learning as much as possible about the virus to make the best treatment decisions possible for their patients. One of the activities put in place is the COVID-19 and Cancer Consortium […]

read more

COVID-19 outcomes with anticancer treatments

There is a lot of ongoing research to understand the effect of cancer and its treatment on the outcomes of patients who contract COVID-19. Cancer patients could be at greater risk from COVID-19 because their immune systems are suppressed or they have other conditions due to their cancer or its treatment. Cancer patients are also […]

read more

Clinical impact of COVID-19 on people with cancer

A recent publication in The Lancet looked at the effect of COVID-19 on the treatment of people with cancer. Data from cancer patients living in the USA, Canada and Spain who were infected with coronavirus were analysed. Nine hundred and twenty eight (928) people with an active or previous cancer and confirmed severe acute respiratory […]

read more

NHS reveals plans to increase hospital services

NHS England have issued a plan for re-instating urgent and scheduled services to help local hospitals begin to increase routine operations and treatment. Patients will start to be scheduled for important planned procedures, including surgery, over the coming weeks. Specialists will prioritise those patients with the most urgent clinical need. Before being admitted to hospital, […]

read more

Patients ‘left in the dark’ by the NHS over cancer treatments

Macmillan Cancer Support has recently published the results from their annual Cancer Patient Experience Survey, which reveals that around 120,000 cancer patients a year feel that topics, such as treatments and side effects, were not fully explained to them by NHS staff. This made them feel “left in the dark” by the NHS. Thirty-nine percent […]

read more

IKCS 2019: Management of small renal masses

In this video interview, Dr Eric Singer from Rutgers Cancer Institute of New Jersey, USA discusses the management of small renal masses at the International Kidney Cancer Symposium (IKCS) in Miami earlier this month. Watch the video interview on Oncology Tube here

read more

New cancer drug payment system could speed up access to treatments

Cancer Research UK and the Greater Manchester Health and Social Care Partnership has produced a report suggesting a new system for reimbursement of cancer drugs by the NHS. The report suggests that paying for cancer drugs based on how well they work in practice could help patients get new treatments faster. This new flexible system, […]

read more

Exercise significantly cuts the risk of death from cancer

New research from an American group based at Roswell Park Comprehensive Cancer Center, New York shows that if cancer patients exercise regularly both before and after their diagnosis, they are significantly more likely to survive cancer than those who are sedentary. This adds to the growing evidence that physical activity is important for the prevention […]

read more

Cancer drugs taking longer to reach NHS patients

A new report by the Institute of Cancer Research (ICR) has found that patients are waiting longer for new cancer drugs to be approved for use with the NHS because of delays in clinical trials and regulatory approval for use. The report found that the average time taken from the start of phase I clinical […]

read more
Showing 1 to 10 of 12 results
  TOP